test

Nir Messafi

@Deep Track Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CNTXContext Therapeutics Inc
Recent Activity
0.47%
$14.542M
7.419M shares@ $1.97 avg price
CYBNCybin Inc
Recent Activity
New Position
0.44%
$13.602M
1.53M shares@ $8.89 avg price
ZURAZura Bio Ltd
Recent Activity
0.43%
$13.332M
3.284M shares@ $4.07 avg price
IVVDInvivyd Inc
Recent Activity
0.36%
$11.173M
10.954M shares@ $1.03 avg price
CLYMEliem Therapeutics Inc
Recent Activity
Decreased -44.44%
0.36%
$11.041M
2.169M shares@ $5.1 avg price
INOInovio Pharmaceuticals Inc
Recent Activity
Decreased -12.69%
0.34%
$10.429M
1.804M shares@ $5.78 avg price
NMRANeumora Therapeutics Inc.
Recent Activity
Increased 314.37%
0.32%
$9.88M↑ Call
747,928 shares@ $13.22 avg price
AVTXAvalo Therapeutics Inc
Recent Activity
New Position
0.3%
$9.187M
967,000 shares@ $9.5 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Decreased -92.78%
0.24%
$7.441M
531,857 shares@ $13.99 avg price
VIGLVigil Neuroscience Inc
Recent Activity
Increased 160.21%
0.17%
$5.284M
1.554M shares@ $3.4 avg price